These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12843137)

  • 1. Statins sentence thyroid cancer cells to death rho.
    Robbins RJ
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3019-20. PubMed ID: 12843137
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of statins in thyroid proliferative disease.
    Bifulco M
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):242-3. PubMed ID: 18301396
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
    Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
    Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
    Fritz G
    Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin-induced cytoskeletal reorganization in lens epithelial cells: role of Rho GTPases.
    Maddala RL; Reddy VN; Rao PV
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2610-5. PubMed ID: 11581207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and Thyroid Carcinoma: a Meta-Analysis.
    Zhao J; Xu C; Yao J; Yu C; Liao L; Dong J
    Cell Physiol Biochem; 2018; 47(4):1422-1431. PubMed ID: 29929194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
    Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
    Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.
    Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3021-6. PubMed ID: 12843138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway.
    Song J; Deng PF; Stinnett SS; Epstein DL; Rao PV
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2424-32. PubMed ID: 15980231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin and sudden unexpected death in epilepsy: a matter for debate.
    Nejm MB; Gouveia TL; da Graça Naffah-Mazacoratti M; Scorza CA; Cavalheiro EA; Scorza FA
    Epilepsy Behav; 2013 Jul; 28(1):10-1. PubMed ID: 23648273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rho and Rho-kinase].
    Sato J; Iiri T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():197-202. PubMed ID: 16897863
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statins: a major therapeutic breakthrough].
    Brun JM
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):91-2. PubMed ID: 11240410
    [No Abstract]   [Full Text] [Related]  

  • 15. Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion.
    Nübel T; Dippold W; Kleinert H; Kaina B; Fritz G
    FASEB J; 2004 Jan; 18(1):140-2. PubMed ID: 14630701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein, coronary risk, and statins.
    Harv Womens Health Watch; 2001 Sep; 9(1):2. PubMed ID: 11572835
    [No Abstract]   [Full Text] [Related]  

  • 17. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiinflammatory effects of statins.
    McCullough PA
    N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of statins in postoperative adhesion prevention.
    van der Wal JB; Jeekel J
    Ann Surg; 2007 Feb; 245(2):185-6. PubMed ID: 17245170
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.
    Hausding M; Witteck A; Rodriguez-Pascual F; von Eichel-Streiber C; Förstermann U; Kleinert H
    Br J Pharmacol; 2000 Oct; 131(3):553-61. PubMed ID: 11015307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.